Revalesio Unveils Groundbreaking Stroke Treatment RNS60 at ASENT Annual Meeting Revalesio showcases its significant advancements in stroke treatment with RNS60 at the ASENT Annual Meeting, highlighting reduced hospital stays and improved outcomes.

Revalesio Unveils Groundbreaking Stroke Treatment RNS60 at ASENT Annual Meeting #United_States #Bethesda #Revalesio #RNS60 #ASENT

Revalesio Unveils Promising Results from Phase 2 RESCUE Trial at SVIN 2025 Revalesio reveals insights from its Phase 2 RESCUE trial, suggesting RNS60 may significantly shorten hospital stays for stroke patients.

Revalesio Unveils Promising Results from Phase 2 RESCUE Trial at SVIN 2025 #United_States #Orlando #Rescue #Revalesio #RNS60

Revalesio to Showcase Promising RNS60 Data at World Stroke Congress 2025 Revalesio will present exciting new data from its RNS60 clinical trial at the World Stroke Congress, highlighting a potential treatment for ischemic stroke.

Revalesio to Showcase Promising RNS60 Data at World Stroke Congress 2025 #USA #Tacoma #Revalesio #RNS60 #World_Stroke_Congress

Revalesio's RNS60 Receives FDA Fast Track Status for Stroke Treatment Revalesio has been granted FDA Fast Track designation for RNS60, aimed at treating acute ischemic stroke, providing hope for patients.

Revalesio's RNS60 Receives FDA Fast Track Status for Stroke Treatment #USA #FDA_Fast_Track #Tacoma #Revalesio #RNS60

Revalesio's RNS60 Shows Promise in Phase 2 Stroke Trial Results Published in 'Stroke' Revalesio's recent publication reveals significant findings from the RESCUE Phase 2 trial of RNS60 as an adjunctive therapy for acute ischemic stroke, with promising outcomes.

Revalesio's RNS60 Shows Promise in Phase 2 Stroke Trial Results Published in 'Stroke' #United_States #Tacoma #Revalesio #RNS60 #Stroke

Revalesio To Unveil Key Findings from RNS60 Trial for Stroke Treatment at SNIS Conference Revalesio announces important presentations regarding its RNS60 treatment for acute ischemic stroke at the SNIS Annual Meeting in July 2025.

Revalesio To Unveil Key Findings from RNS60 Trial for Stroke Treatment at SNIS Conference #United_States #Nashville #Medical_Research #Revalesio #RNS60

Revalesio Reveals Encouraging Phase 2 Results for RNS60 in Stroke Treatment Revalesio has presented promising findings from its Phase 2 RESCUE trial for RNS60, highlighting reduced hospital stays and brain tissue preservation in stroke patients.

Revalesio Reveals Encouraging Phase 2 Results for RNS60 in Stroke Treatment #USA #Tacoma #Revalesio #RNS60 #RESCUE_Trial

New Findings Reveal RNS60 Accelerates Discharge for Stroke Patients, Enhancing Recovery Times Recent Phase 2 trial data shows that RNS60 can significantly reduce hospital stays for ischemic stroke patients, promoting faster recoveries and better health outcomes.

New Findings Reveal RNS60 Accelerates Discharge for Stroke Patients, Enhancing Recovery Times #USA #Tacoma #Revalesio #RNS60 #StrokeRecovery